Annual financial statements

Consolidated Balance Sheet Report as of December 31, 2017

thousand KZT

Description Line code As at the end of the reporting period  As of the beginning of the reporting period
Assets Page code                1 2
I. Short-term assets . . .
Cash assets and their equivalents  010 6 751 184 6 034 709
Available-for-sale financial assets 011 0 0
Derivative financial instruments 012 0 0
Financial assets accountable by fair value through income and losses  013 0 0
Financial assets withheld until retirement  014 0 0
Other short-term financial assets 015 7 833 556 11 184 909
Short-term commercial and other account receivables 016 7 531 484 6 346 116
Current income tax 017 37 258 205 000
Stocks 018 15 794 309 17 071 179
Other short-term assets 019 850 311 1 013 095
Total short-term assets (sum of lines from 010 to 019) 100 38 798 102 41 855 008
Assets (or withdrawn groups) intended for sale  101 0 0
II. Long-term assets . . .
Available-for-sale financial assets 110 0 0
Derivative financial instruments 111 0 0
Financial assets accountable by fair value through income and losses  112 0 0
Financial assets withheld until retirement  113 0 0
Other short-term financial assets 114 0 15 000
Long-term commercial and other account receivable 115 0 0
Investments accounted with equity accounting 116 8 353 356 6 343 208
Investment property 117 0 0
Basic assets 118 19 669 612 20 403 955
Biological assets 119 0 0
Exploration and evaluation assets 120 387 667 406 741
Intangible assets 121 524 425 580 455
Deferred tax assets 122 30 118 43 831
Other long-term assets 123 8 042 637 7 784 751
Total long-term assets (sum of lines from 110 to 123) 200 37 007 815 35 577 941
Balance (line 100 + line 101 + line 200)   75 805 917 77 432 949
Liabilities  Page code As at the end of the reporting period  As of the beginning of the reporting period
III. Short-term liabilities . . .
Loans  210 0 0
Financial derivatives  211 0 0
Other short-term financial liabilities  212 0 0
Short-term commercial debt and other credit debt   213 1 843 709 1 773 990
Short-term reserves 214 424 724 715 590
Current income tax obligations  215 0 0
Staff remuneration 216 536 589 522 873
Other short-term liabilities  217 704 622 1 063 416
Total short-term liabilities(sum of lines from 210 to 217) 300 3 509 644 4 075 869
Liabilities of withdrawn groups intended for sale 301 0 0
IV. Long-term liabilities . . .
Loans  310 0 0
Derivative financial instruments 311 0 0
Other long-term financial liabilities 312 0 0
Long-term commercial and other credit debt 313 0 0
Long-term reserves 314 2 748 657 3 133 206
Deferred tax liabilities 315 1 647 245 1 488 237
Other long-term liabilities 316 1 127 258 1 000 733
Total long-term liabilities (sum of lines from 310 to 316)  400 5 523 160 5 622 176
V. Capital . . .
Authorised (joint-stock) capital  410 2 755 985 2 755 985
Seigniorage revenues 411 0 0
Reacquired private equity instruments 412 0 0
Reserves 413 147 462 128 556
Undistributed profit (outstanding loss) 414 63 869 666 64 850 363
Total capital attributed to parent company owners (sum of lines from 410 to 414) 420 66 773 113 67 734 904
Non-controlling owners interest 421 0 0
Total capital (line 420 +/- line 421) 500 66 773 113 67 734 904
Balance (line 300 + line 301 + line 400 + line 500) . 75 805 917 77 432 949

 

Profit and Loss Consolidated Report for the year ended December 31, 2017

thous. Tenge

Description Line code For the reporting period For previous period
Revenue  010 37 483 584 38 977 206
Cost of sales 011 28 946 380   25 740 350
Gross profit (line 010 - line 011) 012 8 537 204 13 236 856
Distribution expenses 013 1 087 459 1 101 282
Administrative expenses  014   2 847 020 3 126 434
Other expenses 015 0 0
Other income 016 0 0
Total operating income (loss) (+/- lines from 012 to 016) 020    4 602 725                                9 009 140
Finance income 021 311 081                                    427 250
Finance costs 022 336 160                                    553 291
Company's share in profit (loss) of associated entities and joint activity accouting with equity accounting 023   (111 490)                                       (6 690)
Other non-operating income 024    600 685                                    651 571
Other non-operating expenses 025   2 240 659                                    870 169
Profit before income tax  (+/- lines from 020 to 025) 100 2 826 182                                8 657 811
Income tax expense 101 1 362 637                                2 001 168
Income (loss) after coninuing activity taxation (line 100 - line 101) 200 1 463 545                                6 656 643
Income (loss) after dicontinued activity taxation 201 0 0
Profit for the year attributable to: (line 200 + line 201) related to: 300 1 463 545                                6 656 643
parent company owners . 1 463 545                                6 639 226
non-controlling owners interest .   17 417
Other consolidated returns, total (sum of lines 410 to 420): 400 (33 909)                                      32 018
including: . . .
Asset revaluation 410 0 0
Financial assets revaluation available for sale  411 0 0
Share in other comprehensive income of equity method investments 412                              (1 629)                                            670
Actuarial losses on post-employment benefit obligations 413                            (51 186)                                    234 061
Effect of change in income tax rate on deferred tax of branch organizations  414 0 0
Cash hedging  415 0 0
Exchange difference by investments in foreign organizations  416                              18 906                                  (202 713)
Hedging of net investments into foregn operations 417 0 0
Other components of other consolidated returns 418 0 0
Correction at reclassification within income (loss)  419 0 0
Tax effect of other consolidated income components 420 0 0
Total consolidated returns (line 300 + line 400) 500                        1 429 636                                6 688 661
Total consolidated returns attributable  . . .
parent company owners  .                        1 429 636                                6 671 244
non-controlling owners interest . 0                                      17 417
Earnings per share: 600 . .
including: . . .
Basic earnings per share: . . .
of the continuing activity  . 0,601 2,728
of the discontinued activity . . .
Diluted earnings per share: . . .
of the continuing activity  . . .
of the discontinued activity . . .

 

CASH FLOWS CONSOLIDATED REPORT as of 31 December 2017 (direct method)

thous. Tenge

Description Line code For reporting period For previous period
I.  OPERATING ACTIVITY CASH FLOW . . .
1.  Receipt total, 010 40 357 805 43 554 623
     including: . . .
          sale of goods and services 011 37 687 173 40 487 565
          other gain 012 0 0
          advances received from buyers, customers 013 259 440 636 691
          receipts under insurance contracts 014 0 0
          remuneration received  015 260 535 411 444
          other receipts 016 2 150 657 2 018 923
2. Decrease total, 020 37 583 269 36 539 480
     including: . . .
          payments to suppliers for goods and services 021 19 721 505 20 130 418
          advances given to suppliers of goods and services 022 1 198 967 749 326
          payments for labour 023 8 400 806 7 441 127
          remuneration payment   024 0 0
          payments under insurance contracts 025 0 0
          income tax and other payments into the budget 026 4 432 403 5 578 076
          other payments 027 3 829 588 2 640 533
3. Result of operating activity (p.010-p.020) 030 2 774 536 7 015 143
II. INVESTMENT ACTIVITY CASH FLOW  . . .
1. Receipt total, 040 12 110 370 8 846 349
     including: . . .
          fixed assets sale  041 617 657 0
          intangible assets sale  042 0 0
          other long-term assets sale 043 0 0
          sale of other organizations' equity instruments (except for affiliates) and participatory interest in joint ventures 044 0 57 939
          sale of other organizations' debt instruments 045 0 0
          reimbursement in loss of control over subsidiaries 046 0 95 841
          sale of other financial assets 047 11 193 325 8 435 743
          futures and forward contracts, options, and swaps 048 0 0
          devidends received  049 45 756 149 021
          remuneration received  050 0 0
          other receipts 051 253 632 107 805
2. Decrease total, 060 11 796 132 12892418
     including: . . .
        fixed assets acquisition 061 523 854 425 784
        intangible assets acquisition 062 0 0
        other long-term assets acquisition 063 1 417 653 908 978
       acquisition of other organizations' equity instruments (except for affiliates) and participatory interest in joint ventures 064 2 169 023 3 362 006
        acquisition of other organizations' debt instruments 065 0 0
        acquisition of control over subsidiaries 066 0 0
        acquisition of other financial assets 067 7 340 516 8 037 720
        granting of loans  068 334 690 0
        futures and forward contracts, options, and swaps 069 0 0
        investments in associates and subsidiaries 070 0 0
        other payments 071 10 396 157 930
3. Result of investment activity (p.040-p.060) 080 314 238           (4 046 069)
III. FINANCIAL ACTIVITY CASH FLOW . . .
1. Receipt total, 090 0 0
     including: . . .
          issue of equities and other financial instruments  091 0 0
          procurement of a loan  092 0 0
          remuneration receipt 093 0 0
          other receipts  094 0 0
2. Decrease total, 100 2 204 496 2 944 504
     including: . . .
          payment of loans 101 0 0
          payment of remuneration  102 0 0
          payment of devidends 103 2 204 496 2 944 504
          payments to owners under organizations' equities   104 0 0
          other decreases 105 0 0
3. Result of financial activity (p.090-p.100) 110           (2 204 496)           (2 944 504)
4. Influence of currency exchange rate in tenge 120              (167 803)              (399 863)
TOTAL: Increase(+)/decrease(-) of funds (p030+-p080+-p110) 130 716 475                24 570
  Funds as of the beginning of reporting period  140 6 034 709 6 410 002
  Funds as of the ending of reporting period  150 6 751 184 6 034 709

 

Consolidated report on capital change for the year ended on December 31, 2017

thous. Tenge

Description Line code Mother company capital Share of non-controlling owners Total capital
Authorized capital stock Issue income Purchased own share instruments Reserves Undistributed profit
Balance as of January 1st of the previous year 010 2 755 985 0 0 331 269 61 188 370                 (17 417)       64 258 207
Accounting policy change 011 0 0 0 0 0 0 0
Re-calculated balance (line 010 +/- line 011) 100 2 755 985 0 0 331 269 61 188 370                 (17 417)       64 258 207
Total aggregate profit, total (line 210 + line 220): 200 0 0 0         (202 713) 6 873 957                  17 417         6 688 661
Profit (loss) of the year 210 0 0 0 0 6 639 226                  17 417         6 656 643
Other aggregate profit, total (sum of lines from 221 to 229): 220 0 0 0         (202 713)             234 731 0             32 018
including: . . . . . . . .
Increment of fixed assets reappraisal (minus tax effect) 221 0 0 0 0 0 0 0
Transfer of fixed assets reappraisal depreciation (minus tax effect) 222 0 0 0 0 0 0 0
Reappraisal of financial instruments available for sale (minus tax effect) 223 0 0 0 0 0 0 0
Share in other aggregate profit (loss) of the associated agencies and joint activities acounted for by share participation method 224 0 0 0 0                   670 0 670
Acturial profit (loss) of retirement obligations 225 0 0 0 0             234 061 0 234 061
Effect of changing income tax rate by deferred tax of daughter companies 226 0 0 0 0 0 0 0
Fund flow hedging (minus tax effect) 227 0 0 0 0 0 0 0
Rate difference by investments to foreign companies 228 0 0 0         (202 713) 0 0          (202 713)
Hedging of net investment to foreign operations 229 0 0 0 0 0 0 0
Operations with owners, total (sum of lines from 310 to 318): 300 0 0 0 0         (3 211 964) 0        (3 211 964)
including: . 0 0 0 0 0 0 .
Granting shares to the employees: 310 0 0 0 0 0 0 0
including: . . . . . . . .
employee's service cost . 0 0 0 0 0 0 0
issuing shares according to granting shares to employees procedure . 0 0 0 0 0 0 0
tax benefit regarding granting shares to employees procedure . 0 0 0 0 0 0 0
owner fee 311 0 0 0 0 0 0 0
Issuing own share instruments (shares) 312 0 0 0 0 0 0 0
Issuing share instruments associated with business merge  313 0 0 0 0 0 0 0
Share component of the converted instruments (minus tax effect) 314 0 0 0 0 0 0 0
Dividend payment 315 0 0 0 0         (3 211 964) 0        (3 211 964)
Other distribution in favor of owners  316 0 0 0 0 0 0 0
Other operations with owners 317 0 0 0 0 0 0 0
Change of share of participating in daughter companies, not resulted in control loss: 318 0 0 0 0 0 0 0
Other operations 319 0 0 0 0 0 0 0
Balance as of January 1st of the reporting year (line 100 + line 200 + line 300) 400 2 755 985 0 0 128 556 64 850 363 0       67 734 904
Accounting policy change 401 0 0 0 0 0 0 0
Re-calculated balance (line 400 +/- line 401) 500 2 755 985 0 0 128 556 64 850 363 0       67 734 904
Total aggregate profit, total (line 610 + line 620) 600 0 0 0           18 906 1 410 730 0         1 429 636
Profit (loss) of the year 610 0 0 0 0 1 463 545 0         1 463 545
Other aggregate profit, total (sum of lines from 621 to 629): 620 0 0 0           18 906 -52 815 0            (33 909)
including: . . . . . . . .
Increment of fixed assets reappraisal (minus tax effect) 621 0 0 0 0 0 0 0
Transfer of fixed assets reappraisal depreciation (minus tax effect) 622 0 0 0 0 0 0 0
Reappraisal of financial instruments available for sale (minus tax effect) 623 0 0 0 0 0 0 0
Share in other aggregate profit (loss) of the associated agencies and joint activities acounted for by share participation method 624 0 0 0 0               (1 629) 0 (1 629)
Acturial profit (loss) of retirement obligations 625 0 0 0 0              (51 186) 0 (51 186)
Effect of changing income tax rate by deferred tax of daughter companies 626 0 0 0 0 0 0 0
Fund flow hedging (minus tax effect) 627 0 0 0 0 0 0 0
Rate difference by investments to foreign companies 628 0 0 0           18 906 0 0             18 906
Hedging of net investment to foreign operations 629 0 0 0 0 0 0 0
Operations with owners, total (sum of lines from 710 to 718): 700 0 0 0 0         (2 391 427) 0        (2 391 427)
including:   0 0 0 0 0 0 0
Granting shares to the employees: 710 0 0 0 0 0 0 0
including: . . . . . . . 0
employee's service cost . 0 0 0 0 0 0 0
issuing shares according to granting shares to employees procedure . 0 0 0 0 0 0 0
tax benefit regarding granting shares to employees procedure . 0 0 0 0 0 0 0
owner fee 711 0 0 0 0 0 0 0
Issuing own share instruments (shares) 712 0 0 0 0 0 0 0
Issuing share instruments associated with business merge  713 0 0 0 0 0 0 0
Share component of the converted instruments (minus tax effect) 714 0 0 0 0 0 0 0
Dividend payment 715 0 0 0 0         (2 391 427) 0        (2 391 427)
Other distribution in favor of owners  716 0 0 0 0 0 0 0
Other operations with owners 717 0 0 0 0 0 0 0
Change of share of participating in daughter companies, not resulted in control loss: 718 0 0 0 0 0 0 0
Other operations 719 0 0 0 0 0 0 0
Balance as of December 31st of the reporting year (line 500 + line 600 + line 700) 800 2 755 985 0 0 147 462 63 869 666 0 66 773 113